Combinatorial therapy for Cancer: A therapeutic mix encompassing Gedunin,  Atorvastatin, Desipramine, Sulfasalazine (SSZ), SAHA(suberanilohydroxamic acid)/Vorinostat (GADSS)  increases the expression of REV-ERBa, inhibits glioblastoma proliferation, increases interferon-IFNγ signalling, increase antigen presentation and unfolding response, increases Cytotoxic activity of T-cells, decreases tumor burden and increases survival, via up-regulation of its target gene, 21/February/2018, 6.55 am